文献速递肺血管病与心包/心肌炎

BRCC3调控血管平滑肌细胞ALK2在肺动脉高压中的作用

BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
PubMed 文献 · Circulation · 2024-04-01

本研究探讨BRCC3通过去泛素化ALK2调控BMP/TGF-β信号平衡在肺动脉高压中的作用。在PAH患者和实验性肺动脉高压动物的PASMCs中BRCC3显著下调;BRCC3去泛素化ALK2激活Smad1/5/9并抑制TGF-β信号,过表达BRCC3可减轻小鼠肺动脉高压,而Brcc3缺失增加易感性。

要点

  • BRCC3在PAH患者及动物模型的PASMCs中表达下调。
  • BRCC3通过去泛素化ALK2维持BMP信号并抑制TGF-β信号。
  • 过表达BRCC3减轻小鼠肺动脉高压,Brcc3缺失增加易感性。

核心结论

  • BRCC3通过维持BMP信号(ALK2-Smad1/5-PPARγ轴)并抑制TGF-β信号,在维持肺血管稳态中起关键作用,对PAH缓解具有转化意义。

研究设计与样本

  • 研究采用生物信息学分析、培养的肺动脉平滑肌细胞、小鼠模型及特发性PAH患者标本。

主要发现

  • BRCC3在PAH患者和实验性肺动脉高压动物的PASMCs中显著下调。
  • BRCC3去泛素化ALK2的Lys-472和Lys-475位点,激活Smad1/5/9并转录激活PPARγ、p53和Id1。
  • 过表达BRCC3下调TGF-β表达并抑制Smad3磷酸化,减弱TGF-β信号。
  • 体外过表达BRCC3或去泛素化模拟型ALK2-K472/475R减弱PASMC增殖和迁移并增强凋亡。
  • SM22α-BRCC3-Tg小鼠肺动脉高压减轻,Brcc3-/-小鼠实验性肺动脉高压易感性增加。

临床怎么用

  • BRCC3及其调控的ALK2-Smad1/5-PPARγ轴可能成为PAH治疗的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An imbalance of antiproliferative BMP (bone morphogenetic protein) signaling and proliferative TGF-β (transforming growth factor-β) signaling is implicated in the development of pulmonary arterial hypertension (PAH). The posttranslational modification (eg, phosphorylation and ubiquitination) of TGF-β family receptors, including BMPR2 (bone morphogenetic protein type 2 receptor)/ALK2 (activin receptor-like kinase-2) and TGF-βR2/R1, and receptor-regulated Smads significantly affects their activity and thus regulates the target cell fate. BRCC3 modifies the activity and stability of its substrate proteins through K63-dependent deubiquitination. By modulating the posttranslational modifications of the BMP/TGF-β-PPARγ pathway, BRCC3 may play a role in pulmonary vascular remodeling, hence the pathogenesis of PAH. METHODS: Bioinformatic analyses were used to explore the mechanism by which BRCC3 deubiquitinates ALK2. Cultured pulmonary artery smooth muscle cells (PASMCs), mouse models, and specimens from patients with idiopathic PAH were used to investigate the rebalance between BMP and TGF-β signaling in regulating ALK2 phosphorylation and ubiquitination in the context of pulmonary hypertension. RESULTS: BRCC3 was significantly downregulated in PASMCs from patients with PAH and animals with experimental pulmonary hypertension. BRCC3, by de-ubiquitinating ALK2 at Lys-472 and Lys-475, activated receptor-regulated Smad1/5/9, which resulted in transcriptional activation of BMP-regulated PPARγ, p53, and Id1. Overexpression of BRCC3 also attenuated TGF-β signaling by downregulating TGF-β expression and inhibiting phosphorylation of Smad3. Experiments in vitro indicated that overexpression of BRCC3 or the de-ubiquitin-mimetic ALK2-K472/475R attenuated PASMC proliferation and migration and enhanced PASMC apoptosis. In SM22α-BRCC3-Tg mice, pulmonary hypertension was ameliorated because of activation of the ALK2-Smad1/5-PPARγ axis in PASMCs. In contrast, Brcc3-/- mice showed increased susceptibility of experimental pulmonary hypertension because of inhibition of the ALK2-Smad1/5 signaling. CONCLUSIONS: These results suggest a pivotal role of BRCC3 in sustaining pulmonary vascular homeostasis by maintaining the integrity of the BMP signaling (ie, the ALK2-Smad1/5-PPARγ axis) while suppressing TGF-β signaling in PASMCs. Such rebalance of BMP/TGF-β pathways is translationally important for PAH alleviation.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Shen H, Gao Y, Ge D, et al. BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension. Circulation. 2024. PMID: 38557054. doi:10.1161/CIRCULATIONAHA.123.066430

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。